SAN FRANCISCO (EGMN) - Patients who were treated with neoadjuvant therapy for locally advanced breast cancer were more likely to develop clinical recurrence if they had a triple-negative tumor subtype, a study of 131 patients found.Disease progression was seen in 4% of patients with other breast cancer subtypes and in 25% of patients who were negative for estrogen receptor (ER), progesterone receptor (PR), and HER2, Dr. Saira Nasim and associates reported in a poster presentation that won a merit...